Search here...
Subscribe

Error 404 - not found

We couldn't find what you're looking for. Browse our latest stories or categories.

spot_imgspot_img

Finance

Marketing

Politics

Travel

Psychedelics

Clinical Trial Explores Psychedelic Treatment for Depression

LOS ANGELES- In a move within the field of psychiatric treatment, MindBio Therapeutics Corp. has announced the launch...
Psychedelics

Indiana’s Pioneering Psilocybin Research Bill Awaits Governor’s Approval

LOS ANGELES- In a groundbreaking legislative move, Indiana stands on the precipice of advancing psilocybin research, following the...
Psychedelics

Cybin Eyes $150 Million Boost Through Private Placement to Propel Psychedelic Drug Development

Cybin Inc., a firm at the forefront of psychedelic drug development, announced its plan on Wednesday to secure...
Insights

atai Life Sciences Advances VLS-01, A Novel DMT-Based Treatment

LOS ANGELES- atai Life Sciences a biotechnology company specializing in mental health treatments, is making strides in the...
Justice

FDA’s ‘Breakthrough’ Nod to MM120, An LSD-Derivative, for Anxiety Relief

HCN News Team HCN News Team -
LOS ANGELES- In a significant development within the field...
Insights

New Mexico Advances Psilocybin Research with Memorial Legislation

HCN News Team HCN News Team -
-LOS ANGELES- In a significant move toward exploring alternative...
Brands

Numinus Wellness Secures $6 Million in Public Offering to Fuel Psychedelic-Assisted Therapy Initiatives

LOS ANGELES- Numinus Wellness, a Vancouver-based healthcare company specializing in the innovative field of psychedelic-assisted therapies, has announced...
Brands

FSD Pharma Announces Market Offering Agreement to Fund Research and Development

NEW YORK- FSD Pharma a biopharmaceutical company focused on developing a diverse portfolio of innovative assets and biotechnological...
Brands

Clearmind Medicine Inc. Advances Psychedelic Therapeutics with New Patent Applications

NEW YORK– Clearmind Medicine Inc. a biotech firm dedicated to the discovery and development of novel psychedelic-derived therapeutics,...
Brands

MindBio Therapeutics Announces Completion of Groundbreaking Phase 2a LSD Microdose Trial

LOS ANGELES- In a significant advancement for psychiatric medicine, MindBio Therapeutics Corp., a pioneering biopharmaceutical company, has announced...
Brands

Silo Pharma Advances in Ketamine-Based Treatment for Chronic Pain

HCN News Team HCN News Team -
LOS ANGELES— In a significant stride toward innovative treatment...
Brands

PharmaDrug Inc. Completes Private Placement to Bolster Corporate Initiatives

HCN News Team HCN News Team -
LOS ANGELES- a specialty pharmaceutical company, announce the successful...

Follow us

Each template in our ever growing studio library can be added and moved around within any page effortlessly with one click.

Company

Latest news

Clinical Trial Explores Psychedelic Treatment for Depression

Psychedelics 0
LOS ANGELES- In a move within the field of...

Indiana’s Pioneering Psilocybin Research Bill Awaits Governor’s Approval

Psychedelics 0
LOS ANGELES- In a groundbreaking legislative move, Indiana stands...

Cybin Eyes $150 Million Boost Through Private Placement to Propel Psychedelic Drug Development

Psychedelics 0
Cybin Inc., a firm at the forefront of psychedelic...

Popular news

Clinical Trial Explores Psychedelic Treatment for Depression

Psychedelics 0
LOS ANGELES- In a move within the field of...

Indiana’s Pioneering Psilocybin Research Bill Awaits Governor’s Approval

Psychedelics 0
LOS ANGELES- In a groundbreaking legislative move, Indiana stands...

Cybin Eyes $150 Million Boost Through Private Placement to Propel Psychedelic Drug Development

Psychedelics 0
Cybin Inc., a firm at the forefront of psychedelic...

© 2021 tagDiv. All Rights Reserved. Made with Newspaper Theme.